The Online Books Page

Pharmacy -- United States

See also what's at your library, or elsewhere.

Broader terms:

Narrower terms:

Filed under: Pharmacy -- United States

Pharmacist's manual : an informational outline of the Controlled substances act of 1970. (Drug Enforcement Administration, U.S. Dept. of Justice, 1978), by United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs (page images at HathiTrust)
Year book of the American Pharmaceutical Association. (Washington, D.C., 1912), by American Pharmaceutical Association (page images at HathiTrust)
Early American pharmacies : a pictorial catalog of apothecary shop resotrations which are on exhibition in the United States. (American Pharmaceutical Association, 1955), by George B. Griffenhagen (page images at HathiTrust)
Pharmacist's manual : an informational outline of the Controlled Substances Act of 1970 (U.S. Dept. of Justice, Drug Enforcement Administration, 1986), by United States. Drug Enforcement Administration. Office of Diversion Control (page images at HathiTrust)
Pharmacy museums and historical collections. (American Institute of the History of Pharmacy, 1999), by George B. Griffenhagen, Beth D. Fisher, Ernst Walter Stieb, and American Institute of the History of Pharmacy (page images at HathiTrust)
The professional pharmacy; an analysis of prescription department activities; part of the national drug store survey. (American Pharmaceutical Assn., 1935), by Frank Anthony Delgado and United States Bureau of Foreign and Domestic Commerce (page images at HathiTrust)
The drug users. (Office of the Secretary, U.S. Dept. of Health, Education, and Welfare, 1968), by United States. Task Force on Prescription Drugs (page images at HathiTrust)
Systematic amendment of American pharmacy & our pharmacy laws, boards & schools. ([S.l.], 1906), by Oscar Oldberg (page images at HathiTrust; US access only)
Training for pharmacy ... (The Bureau, 1924), by N.Y.) Bureau of Vocational Information (New York (page images at HathiTrust)
Criminal penalty for robbery of controlled substances : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-eighth Congress, first session ... April 7, 1983. (U.S. G.P.O., 1984), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime (page images at HathiTrust)
Orientation manual on disaster preparedness for pharmacists. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Division of Health Mobilization : for sale by the Supt. of Docs., U.S. Govt. Print. Off., 1965), by American Pharmaceutical Association. Committee on Disaster and National Security and United States. Public Health Service. Division of Health Mobilization (page images at HathiTrust)

Filed under: Pharmacy -- United States -- Congresses

Proceedings. (Health Services and Mental Health Administration, 1971), by San Francisco Invitational Conference on Pharmacy Manpower, Donald C. Brodie, Joe B. Graber, National Center for Health Services Research and Development, and Berkeley. School of Pharmacy University of California (page images at HathiTrust; US access only)

Filed under: Pharmacy -- United States -- Directory

Buyers directory for the wholesale drug, chemical, and allied trades (A. Stubbs, 1918) (page images at HathiTrust)

Filed under: Pharmacy -- United States -- History

Drug Supplies in the American Revolution (reprint from a 1961 bulletin), by George B. Griffenhagen (Gutenberg text and illustrated HTML)

Filed under: Pharmacy -- United States -- Periodicals

American druggist. (New York : Hearst Corp., 1923-1972., 1923) (page images at HathiTrust)
American druggist. (Hearst Corp., 1974) (page images at HathiTrust)
The Dixie druggist (n.p., 1913) (page images at HathiTrust)
The Druggists' bulletin. (Geo. S. Davis Med. Publ., 1887) (page images at HathiTrust)

Filed under: Dispensatories -- United States

The American dispensatory, containing the natural, chemical, pharmaceutical and medical history of the different substances employed in medicine, together with the operations of pharmacy (H.C. Carey & I. Lea, 1827), by John Redman Coxe (page images at HathiTrust)
The American new dispensatory : containing general principles of pharmaceutic chemistry, pharmaceutic operations, chemical analysis of the articles of materia medica, materia medica, including several new and valuable articles, the production of the United States, preparations and compositions ... (T. B. Wait, 1810), by James Thacher and James Currie (page images at HathiTrust)
The dispensatory of the United States of America. (Lippincott, 1926), by H. C. Wood, Ivor Griffith, John F. Anderson, Heber Wilkinson Youngken, and Charles H. LaWall (page images at HathiTrust; US access only)
A digest of materia medica and pharmacy; forming a complete pharmacopoeia for the use of physicians, druggists, and students. (Blakiston, 1883), by Albert Merrell (page images at HathiTrust)
The dispensatory of the United States of America (Lippincott, 1858), by George B. Wood and Franklin Bache (page images at HathiTrust)
The American eclectic dispensatory (Moore, Wilstach & Keys, 1854), by John King (page images at HathiTrust)
The American new dispensatory : Containing general principles of pharmaceutick chemistry; chemical analysis of the articles of materia medica; pharmaceutick operations; materia medica, including several new and valuable articles, the production of the United States; preparations & compositions. With an appendix containing an account of mineral waters; medical prescriptions; the nature and medical uses of the gases; medical electricity; galvanism; an abridgment of Dr. Currie's reports on the use of water; the cultivation of the poppy plant, and the method of preparing opium ... The whole compiled from the most approved authors, both European and American. (Thomas B. Wait, 1821), by James Thacher and James Currie (page images at HathiTrust)
The American new dispensatory : Containing general principles of pharmaceutic chemistry; chemical analysis of the articles of materia medica; pharmaceutic operations; materia medica, including several new and valuable articles, the production of the United States; preparations and compositions. With an appendix, containing an account of mineral waters; medical prescriptions; the nature and medical uses of the gases; medical electricity; galvanism; an abridgment of Dr. Currie's reports on the use of water; the cultivation of the poppy plant, and the method of preparing opium ... The whole compiled from the most approved authors, both European and American (Published by Thomas B. Wait and Co. and C. Williams, T. B. Wait and Co., printers, 1813), by James Thacher and James Currie (page images at HathiTrust)

Filed under: Drug development -- United States

Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah. (U.S. G.P.O. :, 2008), by Rural Development United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture (page images at HathiTrust)
Norplant and contraceptive pricing : conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. (U.S. G.P.O. :, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
Oversight of the drug development program of the National Cancer Institute, 1982 : hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, United States Senate, Ninety-seventh Congress, second session on examination of effective alternatives toward correcting deficiencies in the use of experimental drugs on cancer patients, March 5, 1982. (U.S. G.P.O. :, 1982), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight (page images at HathiTrust)

Filed under: Medication errors -- United States

Board and care homes : elderly at risk from mishandled medications : report to the Chairman, Subcommittee on Health and Long-Term Care, Select Committee on Aging, House of Representatives (The Office ;, 1992), by United States General Accounting Office and United States. Congress. House. Select Committee on Aging. Subcommittee on Health and Long-Term Care (page images at HathiTrust)
Magnitude of health risk is uncertain because of limited incidence data (The Office, 2000), by United States General Accounting Office (page images at HathiTrust)
Medical errors : understanding adverse drug events : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... February 1, 2000. (U.S. G.P.O. :, 2000), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)

Filed under: Pharmaceutical museums -- United States

Pharmacy museums (American Institute of the History of Pharmacy, 1956), by George B. Griffenhagen (page images at HathiTrust)

Filed under: Pharmaceutical policy -- United States

Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)
Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton)
Final report (Dept. of Health, Education, and Welfare, 1977), by Education United States. Department of Health (page images at HathiTrust)
Assuring pharmacy services : principles and guidelines for the delivery of mandated pharmacy services in BCHS primary care projects. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Health Services Administration, Bureau of Community Health Services (5600 Fishers Lane), 1980), by United States. Health Services Administration. Bureau of Community Health Services (page images at HathiTrust)
Update of federal activities regarding the use of pneumococcal vaccine. (Congress of the United States, Office of Technology Assessment :, 1984), by United States Congress Office of Technology Assessment (page images at HathiTrust)
Final report of the Advisory Committee on the Food and Drug Administration. (The Committee, 1991), by United States. Dept. of Health and Human Services. Advisory Committee on the Food and Drug Administration (page images at HathiTrust)
Report of the National Commission on Orphan Diseases. (U.S. Dept. of Health & Human Sevices, Public Health Service, Office of the Assistant Secretary for Health, 1989), by National Commission on Orphan Diseases (U.S.) (page images at HathiTrust)
Drug regulation reform--oversight hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session .... (U.S. G.P.O., 1980), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Pharmaceutical innovation--promises and problems hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment and the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, April 27, 1981. (U.S. G.P.O., 1982), by Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources and United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight (page images at HathiTrust)
Drug lag hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981. (U.S. G.P.O., 1983), by Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources (page images at HathiTrust)
Uncertain returns : the multimillion dollar market in reimported pharmaceuticals : a staff report (U.S. G.P.O. :, 1986), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session part 1 (U.S. G.P.O. :, 1989), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
The Food and Drug Administration's process for approving new drugs oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979. (U.S. Govt. Print. Off., 1979), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
The Food and Drug Administration's process for approving new drugs : report (U.S. G.P.O. :, 1980), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
New drug development in the United States (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1995), by United States Food and Drug Administration (page images at HathiTrust)
Pill mills, Medicaid fraud, and the diversion of pharmaceuticals : hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, One Hundred Second Congress, second session, July 29, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Select Committee on Narcotics Abuse and Control (page images at HathiTrust)
RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994. (U.S. G.P.O. :, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993. (U.S. G.P.O. :, 1993), by United States Senate Special Committee on Aging (page images at HathiTrust)
Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991. (U.S. G.P.O. :, 1992), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Department of Veterans Affairs pharmacy program with emphasis on OTC drugs, medical supplies, and dietary supplements : hearing before the Subcommittee on Hospitals and Health Care of the Committee on Veterans' Affairs, House of Representatives, One Hundred Fourth Congress, second session, June 11, 1996. (U.S. G.P.O. :, 1996), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Hospitals and Health Care (page images at HathiTrust)
The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992. (U.S. G.P.O. :, 1993), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
FDA review and approval times : statement of Mary R. Hamilton, Director of Program Evaluation in the Human Services Area, Program Evaluation and Methodology Division, before the Committee on Labor and Human Resources, U.S. Senate / United States General Accounting Office. (The Office ;, 1996), by United States General Accounting Office, Mary R. Hamilton, and United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Oversight hearing on the availability and eligibility for pharmaceutical services provided by the Department of Veterans Affairs : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Eight [sic] Congress, first session, March 19, 2003. (U.S. G.P.O. :, 2004), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health (page images at HathiTrust)
Greater Access to Affordable Pharmaceuticals Act (U.S. G.P.O. :, 2004), by United States Senate Committee on the Judiciary (page images at HathiTrust)
Pharmacist's manual : an informational outline of the Controlled substances act of 1970. (Drug Enforcement Administration, U.S. Department of Justice, 1980), by United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs (page images at HathiTrust)
Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004. (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
Food and Drug Administration's drug approval process (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
Realities of safety and security regarding drug importation (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005. (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
Oxycontin and beyond : examining the role of FDA and DEA in regulating prescription painkillers : hearing before the Subcommittee on Regulatory Affairs of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, September 13, 2005. (U.S. G.P.O. :, 2005), by United States. Congress. House. Committee on Government Reform. Subcommittee on Regulatory Affairs (page images at HathiTrust)
The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007. (U.S. G.P.O. :, 2007), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Prescription drug abuse : what is being done to address this new drug epidemic? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 26, 2006. (U.S. G.P.O. :, 2007), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)
Examining the implications of drug importation : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, July 14, 2004. (U.S. G.P.O. :, 2008), by United States Senate Committee on the Judiciary (page images at HathiTrust)
From test tube to patient : new drug development in the United States. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1990), by United States Food and Drug Administration (page images at HathiTrust)
The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1992. (U.S. G.P.O. :, 1993), by United States Senate Special Committee on Aging (page images at HathiTrust)
FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988. (U.S. G.P.O. :, 1989), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
The war on drugs meets the war on pain : nursing home patients caught in the crossfire : listening session before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 24, 2010. (U.S. G.P.O. :, 2010), by United States Senate Special Committee on Aging (page images at HathiTrust)
Legislative proposal to increase funding for medical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, first session, special hearing. (U.S. G.P.O. :, 1998), by Health and Human Services United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor (page images at HathiTrust)
Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992. (U.S. G.P.O. :, 1993), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
What is the US role in combating the global HIV/AIDS epidemic? (U.S. G.P.O. :, 2000), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)
Department of Veterans Affairs pharmaceutical procurement polcy : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Sixth Congress, second session, July 25, 2000. (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health (page images at HathiTrust)
Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002. (U.S. G.P.O. :, 2002), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001. (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007. (U.S. G.P.O. :, 2013), by Science United States. Congress. Senate. Committee on Commerce (page images at HathiTrust)
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010. (Washington, DC : For sale by the Superintendent of Documents, U.S. Government Printing Office., 2012), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009. (U.S. G.P.O. :, 2012), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
Preliminary report of the survey on drugs for rare disease (U.S. G.P.O., 1982), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Committee report on scheduling of controlled substances, precursors, chemicals and controlled substances analogs : presented at the National Conference on the Control and Diversion of Controlled Substances, San Antonio, Texas, 1987. (U.S. Dept. of Justice, Drug Enforcement Administration, 1988), by Tex.) National Conference on the Control and Diversion of Controlled Substances (3rd : 1987 : San Antonio and United States. Drug Enforcement Administration (page images at HathiTrust)
Committee report on license revocation & management control systems : presented at the National Conference on the Control and Diversion of Controlled Substances,San Antonio, Texas, 1987. (U.S. Dept. of Justice, Drug Enforcement Administration, 1988), by Tex.) National Conference on the Control and Diversion of Controlled Substances (3rd : 1987 : San Antonio and United States. Drug Enforcement Administration (page images at HathiTrust)
An introduction to FDA drug regulation : a manual for pharmacists. (Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research and Office of Regulatory Affairs, 1990), by Center for Drug Evaluation and Research (U.S.) (page images at HathiTrust)
Commission on the Federal Drug Approval Process : final report (U.S. G.P.O., 1982), by United States. Commission on the Federal Drug Approval Process, United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight, and Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources (page images at HathiTrust)
Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014. (Washington : U.S. Government Printing Office, 2014., 2014), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)

More items available under narrower terms.

Help with reading books -- Report a bad link -- Suggest a new listing

Home -- Search -- New Listings -- Authors -- Titles -- Subjects -- Serials

Books -- News -- Features -- Archives -- The Inside Story

Edited by John Mark Ockerbloom (onlinebooks@pobox.upenn.edu)
OBP copyrights and licenses.